Nonneurotoxic tetralin and indan analogs of 3,4-(methylenedioxy)amphetamine (MDA)
Four cyclic analogues of the psychoactive phenethylamine derivative 3,4-(methylenedioxy)amphetamine were studied. These congeners, 5,6- and 4,5-(methylenedioxy)-2-aminoindan (3a and 4a, respectively), and 6,7- and 5,6-(methylenedioxy)-2-aminotetralin (3b and 4b, respectively) were tested for stimulu...
Saved in:
Published in: | Journal of medicinal chemistry Vol. 33; no. 2; pp. 703 - 710 |
---|---|
Main Authors: | , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
American Chemical Society
01-02-1990
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Four cyclic analogues of the psychoactive phenethylamine derivative 3,4-(methylenedioxy)amphetamine were studied. These congeners, 5,6- and 4,5-(methylenedioxy)-2-aminoindan (3a and 4a, respectively), and 6,7- and 5,6-(methylenedioxy)-2-aminotetralin (3b and 4b, respectively) were tested for stimulus generalization in the two-lever drug-discrimination paradigm. Two groups of rats were trained to discriminate either LSD tartrate (0.08 mg/kg) from saline, or (+/-)-MDMA.HCl (1.75 mg/kg) from saline. In addition, a 2-aminoindan (5a) and 2-aminotetralin (5b) congener of the hallucinogenic amphetamine 1-(2,5-dimethoxy-4- methylphenyl)-2-aminopropane (DOM) were also evaluated. None of the methylenedioxy compounds substituted in LSD-trained rats, while both 3a and 3b fully substituted in MDMA-trained rats. Compounds 4a and 4b did not substitute in MDMA-trained rats. Compounds 5a and 5b did not substitute in MDMA-trained rats, although 5a substituted in LSD-trained rats, but with relatively low potency compared to its open-chain counterpart. In view of the now well-established serotonin neurotoxicity of 3,4-(methylenedioxy)amphetamine and its N-methyl homologue 1, 3a and 3b were evaluated and compared to 1 for similar toxic effects following a single acute dose of 40 mg/kg sc. Sacrifice at 1 week showed that neither 3a nor 3b depressed rat cortical or hippocampal 5-HT or 5-HIAA levels nor were the number of binding sites (Bmax) depressed for [3H]paroxetine. By contrast, and in agreement with other reports, 1 significantly depressed all three indices of neurotoxicity. These results indicate that 3a and 3b have acute behavioral pharmacology similar to 1 but that they lack similar serotonin neurotoxicity. |
---|---|
AbstractList | Four cyclic analogues of the psychoactive phenethylamine derivative 3,4-(methylenedioxy)amphetamine were studied. These congeners, 5,6- and 4,5-(methylenedioxy)-2-aminoindan (3a and 4a, respectively), and 6,7- and 5,6-(methylenedioxy)-2-aminotetralin (3b and 4b, respectively) were tested for stimulus generalization in the two-lever drug-discrimination paradigm. Two groups of rats were trained to discriminate either LSD tartrate (0.08 mg/kg) from saline, or (+/-)-MDMA.HCl (1.75 mg/kg) from saline. In addition, a 2-aminoindan (5a) and 2-aminotetralin (5b) congener of the hallucinogenic amphetamine 1-(2,5-dimethoxy-4- methylphenyl)-2-aminopropane (DOM) were also evaluated. None of the methylenedioxy compounds substituted in LSD-trained rats, while both 3a and 3b fully substituted in MDMA-trained rats. Compounds 4a and 4b did not substitute in MDMA-trained rats. Compounds 5a and 5b did not substitute in MDMA-trained rats, although 5a substituted in LSD-trained rats, but with relatively low potency compared to its open-chain counterpart. In view of the now well-established serotonin neurotoxicity of 3,4-(methylenedioxy)amphetamine and its N-methyl homologue 1, 3a and 3b were evaluated and compared to 1 for similar toxic effects following a single acute dose of 40 mg/kg sc. Sacrifice at 1 week showed that neither 3a nor 3b depressed rat cortical or hippocampal 5-HT or 5-HIAA levels nor were the number of binding sites (Bmax) depressed for [3H]paroxetine. By contrast, and in agreement with other reports, 1 significantly depressed all three indices of neurotoxicity. These results indicate that 3a and 3b have acute behavioral pharmacology similar to 1 but that they lack similar serotonin neurotoxicity. |
Author | Riggs, Robert M Nichols, David E Oberlender, Robert Johnson, Michael P Brewster, William K |
Author_xml | – sequence: 1 givenname: David E surname: Nichols fullname: Nichols, David E – sequence: 2 givenname: William K surname: Brewster fullname: Brewster, William K – sequence: 3 givenname: Michael P surname: Johnson fullname: Johnson, Michael P – sequence: 4 givenname: Robert surname: Oberlender fullname: Oberlender, Robert – sequence: 5 givenname: Robert M surname: Riggs fullname: Riggs, Robert M |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/1967651$$D View this record in MEDLINE/PubMed |
BookMark | eNptkM9PwjAUgBuDQUBPnk12E6LTdl239Yj4k6BixIuX5q3tZLi1ZB0J_PdCZtSDp_eS78t7yddFLWONRuiY4AuCA3K5KDEmUQiYxnuoQ1iA_TDBYQt1MA4CP4gCeoC6zi0wxpQEtI3ahEdxxEgHvTxZY_SqsrVd59KrdV1BkRsPjPJyo2C3QWE_nGczj56Hfr_U9XxTaKNVbtebAZTLua6hzI32-o_Xw8Eh2s-gcProe_bQ2-3NbHTvT57vHkbDiQ-UhbXPQ6k0SCUTGRNFcSwzkkWccs5olipIZMok45ymLAm5ooFOKUQsAa44pIzRHjpr7srKOlfpTCyrvIRqIwgWuy7iT5etfdLYy1VaavXrNiG23G947mq9_sFQfYoopjETs-mr4O9XjI6nkRhv_dPGB-nEwq6qbSX37-cvg8l62g |
CitedBy_id | crossref_primary_10_1002_jrs_4957 crossref_primary_10_1002_aoc_1777 crossref_primary_10_1097_FBP_0000000000000237 crossref_primary_10_1016_0014_2999_92_90282_9 crossref_primary_10_1517_13543776_16_5_587 crossref_primary_10_1124_jpet_116_236349 crossref_primary_10_3109_15563650_2011_615318 crossref_primary_10_1002_hup_1255 crossref_primary_10_1039_c4np00010b crossref_primary_10_1002_dta_310 crossref_primary_10_1016_j_tet_2010_11_066 crossref_primary_10_1016_j_pbb_2004_01_008 crossref_primary_10_1177_1178646919873925 crossref_primary_10_1021_jm9705925 crossref_primary_10_1016_j_tet_2004_06_080 crossref_primary_10_1039_C7CC02608K crossref_primary_10_3389_fpsyt_2017_00236 crossref_primary_10_1016_0091_3057_91_90106_C crossref_primary_10_1016_S0091_3057_97_00557_1 crossref_primary_10_1017_S1461145713001405 crossref_primary_10_1039_c3ra46124f crossref_primary_10_1016_j_pnpbp_2016_04_004 crossref_primary_10_1021_acssynbio_0c00172 crossref_primary_10_1016_S0006_8993_97_00110_8 crossref_primary_10_1016_0014_2999_91_90659_E crossref_primary_10_1016_S0163_7258_02_00234_6 crossref_primary_10_1002_dta_1434 crossref_primary_10_1016_j_bmcl_2006_11_061 crossref_primary_10_1016_j_jorganchem_2021_122012 crossref_primary_10_1016_S0968_0896_00_00048_1 crossref_primary_10_1039_C5AN00591D crossref_primary_10_3109_15563650_2011_645952 crossref_primary_10_1002_1098_2299_200010_51_2_52__AID_DDR2_3_0_CO_2_H crossref_primary_10_1016_S0091_3057_01_00669_4 crossref_primary_10_1021_acs_orglett_1c02767 crossref_primary_10_1016_j_ejphar_2006_07_011 crossref_primary_10_1002_chin_199025136 crossref_primary_10_1002_dta_3622 crossref_primary_10_1016_S0968_0896_03_00053_1 crossref_primary_10_1039_c0ob01214a crossref_primary_10_1177_0269881120920420 crossref_primary_10_1016_j_toxlet_2013_01_008 crossref_primary_10_1080_00498254_2016_1199919 crossref_primary_10_1016_0014_2999_93_90859_G crossref_primary_10_1007_s00213_019_05207_1 crossref_primary_10_3390_ijms24031882 crossref_primary_10_1111_j_1749_6632_2000_tb05194_x crossref_primary_10_1080_00958972_2013_770845 crossref_primary_10_1111_j_2042_7158_1997_tb06758_x crossref_primary_10_1016_S0379_0738_00_00296_6 crossref_primary_10_1080_00498250600967541 crossref_primary_10_1002_wfs2_1197 crossref_primary_10_1016_j_ejmech_2021_113964 crossref_primary_10_1016_j_neuropharm_2014_01_015 crossref_primary_10_1002_dta_318 crossref_primary_10_1016_0091_3057_91_90017_V crossref_primary_10_1016_j_tips_2006_10_006 crossref_primary_10_1111_j_1749_6632_1992_tb25975_x crossref_primary_10_1002_recl_19931120211 crossref_primary_10_1208_aapsj0901001 crossref_primary_10_1016_0091_3057_91_90601_W crossref_primary_10_1039_C2AN35974J crossref_primary_10_1111_j_1747_0285_2009_00845_x crossref_primary_10_1002_hup_2298 crossref_primary_10_1016_j_neuropharm_2017_10_003 crossref_primary_10_1016_0006_2952_96_00482_0 crossref_primary_10_1002_jhet_5570280325 crossref_primary_10_1038_npp_2013_331 crossref_primary_10_1016_j_bcp_2014_01_024 |
ContentType | Journal Article |
DBID | BSCLL CGR CUY CVF ECM EIF NPM AAYXX CITATION |
DOI | 10.1021/jm00164a037 |
DatabaseName | Istex Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1520-4804 |
EndPage | 710 |
ExternalDocumentID | 10_1021_jm00164a037 1967651 ark_67375_TPS_9ZB53JP6_J b638488246 |
Genre | Research Support, U.S. Gov't, P.H.S Journal Article |
GrantInformation_xml | – fundername: NIDA NIH HHS grantid: DA-04758 |
GroupedDBID | - 08R 1WB 3EH 53G 55 55A 5GY 5RE 5VS 9M8 AABXI ABFLS ABMVS ABOCM ABPTK ACGFS ACJ ACS AENEX AFFNX AGXLV AJYGW ALMA_UNASSIGNED_HOLDINGS ANTXH AQSVZ BAANH CS3 DU5 F5P GJ HR JG JG~ L7B LG6 MVM NHB OHT P2P RNS ROL TN5 W1F WH7 X X7M XFK YZZ ZE2 ZGI --- -~X .55 .GJ .HR .K2 6TJ AAHBH ABHMW ABJNI ACGFO BSCLL CUPRZ EBS GGK IH2 VG9 XSW YQT 1KJ 3O- 4.4 6P2 7~N AAYOK ABQRX ABTAH ABUCX ADHLV AEESW AFEFF AHGAQ CGR CUY CVF ECM ED~ EIF EJD GNL IH9 IHE NPM UBC UI2 VF5 ZY4 AAYXX CITATION |
ID | FETCH-LOGICAL-a354t-94cdeacdc8c71d307cf1f6939953fbda8cb5c5993b5849d32eb3a658a9d9ab553 |
IEDL.DBID | ACS |
ISSN | 0022-2623 |
IngestDate | Fri Aug 23 02:53:20 EDT 2024 Sat Sep 28 08:33:45 EDT 2024 Wed Oct 30 09:48:20 EDT 2024 Thu Aug 27 13:42:11 EDT 2020 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-a354t-94cdeacdc8c71d307cf1f6939953fbda8cb5c5993b5849d32eb3a658a9d9ab553 |
Notes | istex:31232F1E9128B0F3433606DC8BA73A4817F12928 ark:/67375/TPS-9ZB53JP6-J |
PMID | 1967651 |
PageCount | 8 |
ParticipantIDs | crossref_primary_10_1021_jm00164a037 pubmed_primary_1967651 istex_primary_ark_67375_TPS_9ZB53JP6_J acs_journals_10_1021_jm00164a037 |
ProviderPackageCode | JG~ 55A AABXI ACS ACJ AGXLV ABMVS 1WB BAANH AQSVZ W1F ANTXH |
PublicationCentury | 1900 |
PublicationDate | 1990-02-01 |
PublicationDateYYYYMMDD | 1990-02-01 |
PublicationDate_xml | – month: 02 year: 1990 text: 1990-02-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of medicinal chemistry |
PublicationTitleAlternate | J. Med. Chem |
PublicationYear | 1990 |
Publisher | American Chemical Society |
Publisher_xml | – name: American Chemical Society |
SSID | ssj0003123 |
Score | 1.6404645 |
Snippet | Four cyclic analogues of the psychoactive phenethylamine derivative 3,4-(methylenedioxy)amphetamine were studied. These congeners, 5,6- and... |
SourceID | crossref pubmed istex acs |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 703 |
SubjectTerms | 3,4-Methylenedioxyamphetamine - analogs & derivatives 3,4-Methylenedioxyamphetamine - chemical synthesis Amphetamines - chemical synthesis Animals Behavior, Animal - drug effects Catecholamines - metabolism Cerebral Cortex - metabolism Hippocampus - metabolism Indans Lysergic Acid Diethylamide N-Methyl-3,4-methylenedioxyamphetamine Paroxetine Piperidines - metabolism Psychotropic Drugs - chemical synthesis Psychotropic Drugs - pharmacology Rats Serotonin - metabolism Structure-Activity Relationship Tetrahydronaphthalenes |
Title | Nonneurotoxic tetralin and indan analogs of 3,4-(methylenedioxy)amphetamine (MDA) |
URI | http://dx.doi.org/10.1021/jm00164a037 https://api.istex.fr/ark:/67375/TPS-9ZB53JP6-J/fulltext.pdf https://www.ncbi.nlm.nih.gov/pubmed/1967651 |
Volume | 33 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9swED_W9mF72bpuZem2oocutBCzyPqyHru0pRRWMpLB2IuR9QHdqF1iB5L_fic7aWhZ2d78IAtxJ93vd6e7E8CRtLTQivpEDjlPePAhyahMEwRzOmReaR9iwO1yoq5_ZGfnsU3Opydu8FP6-ddt2wbKDJnagp1UIUeIDGg0uTe4jKZs3RQ8RThfleE9-jnCj60fwM9OlOTiEaFsgeXi1X8uaRderpgjOe1U_Rqe-XIPno_WD7btQX_ctaFeDsh0U1VVD0ifjDcNqpdv4Nt1zG6Zz6qmWtxY0vg22lESUzoSXfT4FWM6NakCYQOeHMd3ppeIT4h01WJ5YnAL-MbcIkMlx1_PTk_ewveL8-noMlk9rZAYJniTaG4dmlxnM6uow3NuAw1SxzpXFgpnMlsIK5C7FEhQtGMp-twGyYrRTptCCLYP22VV-ndAfIFGIHgruee88CYTyAAzpbw03ngXekBQ7vnqaNR5e-udotexEWIPjtZKye-6Jht_H9ZvFXY_xsx-x7w0JfLpeJLrn18EuxrL_KoH-51GN7NpqaSgB_9ey3t4QRGhu8TsD7DdzOb-I2zVbn7Y7ro_h5jNOA |
link.rule.ids | 315,782,786,2769,27085,27933,27934,56747,56797 |
linkProvider | American Chemical Society |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ba9swFD6s7UP30m3dyrKrHkpoIWaRdbH12KUtWdeGjGQw9mJkXWAbtUvsQPLvd2QnNSuDsTc_yELoSPo-HZ3zHYBjaWiuEuoiOeQ84t75KKUyjhDM6ZC5RDkfHG7jWTL5lp5fBJmcwTYXBgdRYU9V84jfqQvQDz9vGzUoPWTJDuwJiTQ4EKHR7P7cZTRmW23wGFF9k4334OeAQqb6A4X2woSuHvDKBl8un_zfyJ7CwYZHkrPW8M_gkSsOYX-0Ld92CP1pK0q9HpB5l2NVDUifTDu56vVz-DIJsS7LRVmXqx-G1K7xfRREF5aEC3v4Ch6eipSesAGPTkLV6TWiFeJeuVqfalwQrta3yFfJyc352ekL-Hp5MR-No02hhUgzwetIcWPxALYmNQm1uOuNp16qkPXKfG51anJhBDKZHOmKsizGG7hG6qKVVToXgh3BblEW7iUQl-OR4J2R3HGeO50K5INpkjipnXbW94DgHGabjVJlzRt4jHeQbhJ7cLy1TXbXSm78vVm_sdt9G734FaLUEpHNp7NMff8o2NVUZlc9OGoN2_WmZCIFffXvsbyH_fH85jq7_jT5_BoeU8TuNmT7DezWi6V7CzuVXb5rFuJvT1nVpQ |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ba9swFBZrC1tfdulWml31UEILMY2sm_WYJQ1dtwWPZDD2YmRdYBu1S-xA8u93ZDsNK4OxNz_I4nB0pO87ks4nhE6FIbmSxEViyFjEvPNRQkQcAZiTIXVSOR823K7mcvYtmVwGmZzhthYGjKigp6o5xA-z-tb6TmGAXPy8aRSh9JDKPXTAhVQh3RqN53drLyUx3eqDx4DsXUXevZ8DEpnqDyQ6CE5d3-OWDcZMn_y_dU_R445P4lEbAM_QA1ccoUfj7TNuR6iftuLUmwFe7GqtqgHu43QnW715jr7Mwp2X1bKsy_UPg2vX7IEUWBcWh8Q9fIWdngqXHtMBi87C69MbQC3Av3K9OdcQGK7WN8Bb8dnnyej8Bfo6vVyMr6LuwYVIU87qSDFjYSG2JjGSWJj9xhMvVKh-pT63OjE5NxwYTQ60RVkaQyaugcJoZZXOOafHaL8oC3eCsMthafDOCOYYy51OOPDCREontNPO-h7C4MesmzBV1pyFx5CL7JzYQ6fb8cluW-mNvzfrN2N310Yvf4XbapJni3Seqe_vOb1ORXbdQ8ft4O56U0IKTl7-25Z36GE6mWafPsw-vkKHBCC8vbn9Gu3Xy5V7g_Yqu3rbxOJvfULYKA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nonneurotoxic+tetralin+and+indan+analogues+of+3%2C4-%28methylenedioxy%29amphetamine+%28MDA%29&rft.jtitle=Journal+of+medicinal+chemistry&rft.au=Nichols%2C+D+E&rft.au=Brewster%2C+W+K&rft.au=Johnson%2C+M+P&rft.au=Oberlender%2C+R&rft.date=1990-02-01&rft.issn=0022-2623&rft.volume=33&rft.issue=2&rft.spage=703&rft_id=info:doi/10.1021%2Fjm00164a037&rft_id=info%3Apmid%2F1967651&rft.externalDocID=1967651 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-2623&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-2623&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-2623&client=summon |